Gazyva 1,000 MG/40 ML vial 40ML
Ended Awarded
- Contract number
- SPE2DB25FJT83
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,095
Award facts
- Contract value 100% obligated
- $19,094.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,094.72 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Gazyva (obinutuzumab) 1,000 mg/40 ml vials. This is a firm fixed-price, non-set-aside contract with a completion date of September 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Gazyva is a monoclonal antibody used primarily in the treatment of certain blood cancers, including chronic lymphocytic leukemia and follicular lymphoma, reflecting the Defense Logistics Agency Medical Supply Chain's ongoing need to support military and veteran healthcare systems with specialized oncology medications.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated capability to meet federal procurement requirements through competitive award processes and serves critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FJT83?
SPE2DB25FJT83 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FJT83 worth?
The government has obligated $19,095 on SPE2DB25FJT83.
Is contract SPE2DB25FJT83 an order under another contract?
Yes. SPE2DB25FJT83 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJT83 competed?
The extent of competition for SPE2DB25FJT83 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award